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Abstract
Background: There are identified gaps in the care provided to children with cancer based on the self-identified
lack of education for health care professionals in pediatric palliative care and in the perceptions of bereaved
parents who describe suboptimal care. In order to address these gaps, we will implement and evaluate a national
roll-out of Education in Palliative and End-of-Life Care for Pediatrics (EPEC®-Pediatrics), using a ‘Train-the-Trainer’
model.
Methods/design: In this study we are using a pre- post-test design and an integrated knowledge translation
approach to assess the impact of the educational roll-out in four areas: 1) self-assessed knowledge of health
professionals; 2) knowledge dissemination outcomes; 3) practice change outcomes; and 4) quality of palliative care.
The quality of palliative care will be assessed using data from three sources: a) parent and child surveys about
symptoms, quality of life and care provided; b) health record reviews of deceased patients; and c) bereaved parent
surveys about end-of-life and bereavement care. After being trained in EPEC®-Pediatrics, ‘Master Facilitators’ will
train ‘Regional Teams’ affiliated with 16 pediatric oncology programs in Canada. Each team will consist of three to
five health professionals representing oncology, palliative care, and the community. Each team member will
complete online modules and attend one of two face-to-face conferences, where they will receive training and
materials to teach the EPEC®-Pediatrics curriculum to ‘End-Users’ in their region. Regional Teams will also choose a
Tailored Implementation of Practice Standards (TIPS) Kit to guide implementation of a quality improvement project in
their region; support will be provided via quarterly meetings with Co-Leads and via a listserv and webinars with
other teams.
Discussion: Through this study we aim to raise the level of pediatric palliative care education amongst health care
professionals in Canada. Our study will be a significant step forward in evaluation of the impact of EPEC®-Pediatrics
both on dissemination outcomes and on care quality at a national level. Based on the anticipated success of our
project we hope to expand the EPEC®-Pediatrics roll-out to health professionals who care for children with non-
oncological life-threatening conditions.
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Background
Despite significant improvements in treatment, childhood
cancer remains a leading cause of non-accidental death in
children beyond infancy [1]. Annually in Canada, about
10,000 children are living with cancer (both those receiv-
ing cancer treatments and long-term survivors) and ap-
proximately 210 will die from their disease [2]. Even when
a child survives, from the moment of diagnosis the threat
of death may be foremost in the mind of the parents, sib-
lings, and ill child. The treatments aimed at achieving sur-
vival are generally intensive with a significant symptom
burden that is often long-lasting and disruptive to the life
of the child and family [3].
Palliative care for children focuses on alleviating the
physical, social, psychological, and spiritual suffering expe-
rienced by children and families, while promoting quality
of life, fostering family connections, and sustaining hope
despite the possibility of death. It is a family-centered ap-
proach that includes shared decision-making and sensitivity
to the family’s cultural and spiritual values, beliefs, and
practices [4]. In relation to pediatric cancer, palliative care
has historically been thought of as being relevant only once
all treatments with curative intent have been discontinued,
and is offered as an alternative rather than a concurrent
treatment [5]. However, emerging data suggest that princi-
ples of palliative care can and should be incorporated from
diagnosis and throughout the disease course, not only at
the end of life, to ensure relief of suffering and good quality
of life regardless of the disease outcome [6–10]. Consult-
ation from specialist palliative care teams may be helpful
for more complex situations [3].
Oncologists and other health professionals report re-
ceiving little training specific to pediatric palliative care
(PPC) [11–13]. This lack of training may contribute to
reports of less than optimal care in this area: parents’ re-
port that children with cancer experience a great deal of
suffering from pain and other symptoms left inad-
equately treated [14, 15]; some parents feel abandoned
by health professionals both before and after their child’s
death [16, 17]; family-centered care is not uniformly
practiced [12]; and siblings’ needs are not always ad-
equately addressed [12, 18]. To realize improvements in
these areas, it is crucial that all health professionals who
provide care to children with cancer receive comprehensive
education about PPC as well as guidance and support to
implement new knowledge and skills throughout the dis-
ease course. Moreover, efforts are needed to enhance col-
laboration between pediatric oncology and specialists in
PPC. Such efforts will build familiarity, trust, and relation-
ships, thereby facilitating concurrent delivery of disease-
directed and palliative care to children living with cancer
[3]. To achieve these goals, we will implement a national
roll-out of Education in Palliative and End-of-Life Care for
Pediatrics (EPEC®-Pediatrics) [19], a curriculum specifically
designed for pediatric physicians and advanced practice
nurses using a ‘Train-the-Trainer’ model.
Built on the demonstrated success of the original EPEC™
curriculum [20], focused on care of adults, EPEC®-
Pediatrics combines didactic sessions, video presentations,
interactive discussions, and practice exercises. It is com-
prised of 24 modules that can be taught face-to-face to
interprofessional End-Users by EPEC®-Pediatrics Trainers.
The Trainers learn the content via 19 online modules plus
5 delivered at a one and a half day in-person conference
by EPEC®-Pediatrics Master Facilitators demonstrating
effective adult teaching. Funded by a US$ 1.6 million
National Institutes of Health/National Cancer Institute (1
R25 CA151000-01) grant from 2010-2015, Friedrichsdorf
et al. developed the curriculum in collaboration with 35
national and international leaders in the field of paediatric
pain medicine, hematology/oncology and palliative care as
well as parent advisors [21]. A list of the modules is
provided in Table 1. Following initial development, the
Table 1 EPEC®-Pediatrics modules
Title Mode of deliverya
1 Pediatric Palliative Care: Why Does it Matter Online
2 Child Development Online
3 Family Centered Care Online
4 Grief and Bereavement Online
5 Self-Care for Professionals Face-to-Face
6 Team Collaboration and Effectiveness Face-to-Face
7 Communication and Planning Face-to-Face
8 Ethical and Legal Considerations Online
9 Teaching with EPEC®-Pediatrics in
the Face-to-Face Setting
Face-to-Face
10 Multimodal Analgesia Online
11 Opioid Selection and Rotation Online
12 Management of Neuropathic Pain and
Adjuvant Analgesia
Online
13 Procedural Pain Management Strategies Online
14 Chronic Complex Pain Management Online
15 Management of Gastrointestinal Symptoms Online
16 Management of Respiratory Symptoms Online
17 Management of Emotional and Behavioral
Symptoms
Online
18 Management of Neurologic Symptom Online
19 Palliative Sedation Online
20 Preparing for Imminent Death Online
21 Integrative Medicine Online
22 Introducing Quality Improvement to PPC Online
23 Teaching Pain and Symptom Management Face-to-Face
24 Methadone Online
aOnline for education of EPEC-Pediatric Trainers; all modules will be taught
face-to-face to the End-User
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curriculum was refined between 2012 and 2014 based on a
beta testing conference and three subsequent Train-the-
Trainer conferences with 200 pediatric physicians and
advanced practice nurses in the United States and 19 other
countries. All EPEC®-Pediatrics content is evidence-based
and is delivered according to effective adult-education
pedagogy. EPEC®-Pediatrics uses a Train-the-Trainer
model; participants learn the content as well as obtain
effective strategies and resources to educate others. In a
recent systematic review, use of a Train-the-Trainer model
was shown to be effective in improving knowledge and
skills of health professionals, enhancing dissemination, and
having a positive impact on patient outcomes [22].
While data on the effective dissemination of EPEC®-
Pediatrics and EPEC™ is favorable [20], the impact on
patient/family outcomes has not yet been measured.
Recognition that education does not necessarily lead to
significant improvements has led to a strong emphasis
within the EPEC®-Pediatrics curriculum in each module
to address “attitudes” (myths, misconceptions, obstacles)
as well as providing a “skill” in addition to sharing
“knowledge” in hopes of behavior changes among the
Trainers and End-Users [23, 24]. To increase the chance
of practice change toward better clinical pediatric care,
the curriculum added the Tailored Implementation of
Practice Standards (TIPS) Kit to the suite of resources
available through EPEC™. Each TIPS Kit includes a
protocol for an evidence-based clinical intervention (e.g.
symptom management protocol), a guide for how to
adapt the protocol to meet local needs, a template for
evaluation measures, and detailed plans for quality
improvement (QI) methods for implementation. TIPS Kits
reduce the initial time investment needed to develop a QI
project by providing a limited number of possible actions
and measurement options to select from. The EPEC®-
Pediatrics curriculum currently includes one TIPS Kit,
which aims to standardize symptom assessment for
children with serious illness using two pediatric versions
of the Memorial Symptom Assessment Scale [25, 26].
In our study, the content of EPEC®-Pediatrics will not
be changed; however, four key features will be added to
the delivery process based on implementation science
[27] to promote sustained improvement in the quality of
palliative care for children with cancer and their families.
1) Rather than attending as individuals, Regional Teams
of three to five health professionals representing oncol-
ogy, palliative care, and the community (e.g., home care
nurses, community pediatricians) will attend a Train-
the-Trainer Conference together in 2015 and work as a
team. 2) A second day will be added to the Conference
to allow Regional Teams to review data collected in the
pre-test period and use those data to develop regional
dissemination strategies and plan their QI project. 3)
The Research Team developed two additional TIPS Kits
to provide a wider choice of QI projects. 4) Ongoing
support will be provided by the Research Team for edu-
cation and QI initiatives throughout the intervention
period, 2015 - 2016. Teams will also communicate with
each other via a listserv and webinars to share successes
and challenges.
The effectiveness of our EPEC®-Pediatrics roll-out will
be assessed according to four outcomes. The guiding re-
search questions are: What is the impact of EPEC®-
Pediatrics on: 1) the self-assessed knowledge of health
professionals who take part in the curriculum; 2) know-
ledge transfer and dissemination outcomes; 3) practice
change outcomes, and 4) the quality of palliative care
provided to children with cancer and their families?
Methods/design
Design
In this study we will use a pre-post-test design and an
integrated knowledge translation (KT) approach with in-
volvement of knowledge users and key-stakeholders
through the project [28]. The pre-test period will begin
in January 2015 and the post-test period will begin in
the fall of 2016. This timeline allows for the educational
rollout of EPEC®-Pediatrics and QI to occur over ap-
proximately 15 months. Data collection and analysis will
occur in three streams in order to answer the research
questions: 1) knowledge dissemination, 2) quality im-
provement, and 3) care quality. The study has been ap-
proved by the Research Ethics Board (REB) at the
Hospital for Sick Children (#1000047116) as the primary
site as well as by the relevant REB for each participating
site (See Additional file 1 for a list of sites with the cor-
responding REB).
Stream 1 - Knowledge dissemination
Data collection and analysis in Stream 1 will address the
impact of EPEC®-Pediatrics on the self-assessed know-
ledge of health professionals who take part in the cur-
riculum and on knowledge transfer and dissemination
outcomes.
Sample and procedure
The EPEC®-Pediatrics roll-out will include training of five
Master Facilitators within Canada; Master Facilitators are
individuals qualified to train future EPEC®-Pediatrics
Trainers at the face-to-face conference. There are 3 steps to
becoming a Master Facilitator: 1) become an EPEC®-
Pediatrics Trainer by completing all 19 online modules and
attending a face-to-face conference as a participant; 2) at-
tend a Professional Development Workshop offered by
EPEC for additional development of teaching skills, and fi-
nally 3) teach at an EPEC®-Pediatrics Train-the-Trainer
conference where feedback is provided on teaching skills by
existing Master Facilitators. At each of the 16 participating
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sites, 3 to 5 health professionals will be identified as Re-
gional Team members. Each Regional Team member
(n = 45-80) will become an EPEC®-Pediatrics Trainer
through completion of 19 online-modules and 5 face-
to-face modules. Two face-to-face sessions will be held
over two full days with the content delivered by the new
Canadian Master Facilitators in conjunction with the ori-
ginal developers of EPEC®-Pediatrics. Regional Teams will
complete the online modules on their own, then attend
one of the two-day sessions as a team. At the end of the
face-to-face session the new Trainers will be asked to pro-
vide feedback on EPEC®-Pediatrics as a whole and assess
their learning as part of the process. Feedback will be
sought using a Knowledge Transfer and Exchange (KTE)
Survey completed in paper based format.
Once Regional Team members have completed their
training they will work to deliver aspects of the EPEC®-
Pediatrics curriculum to End-Users at their local site.
Trainers will be encouraged to think very broadly about
who provides care to children with cancer within the in-
stitution where they are based, within the local commu-
nity, and more broadly in the wider geographic area
served by the hospital. Education sessions may be of-
fered as part of existing structures (e.g., resident training
session, education days for nurses, academic rounds,
lunch and learns) or as separate sessions delivered spe-
cifically for the study. When End-Users attend an
EPEC®-Pediatrics session, they will be provided with a
consent form that gives details about our study. If they
agree to take part, End-Users will be asked to complete the
KTE Survey in hard copy to assess the impact of the ses-
sion on knowledge transfer. Even if people in attendance
do not want to take part in the research aspect of the ses-
sion they are still welcome to attend. The Trainers who de-
liver the session will collect the surveys and submit them
to the core study team via Research Electronic Data Cap-
ture (REDCap™) database, which is a secure, web-based ap-
plication designed specifically for clinical research [29].
Regional Team members will be asked to complete an
Education Roll-out Report on a quarterly basis to pro-
vide summary information about the education sessions
they have delivered to local End-Users. The Report will
be completed verbally with the Project Manager/Princi-
pal Investigators (PI) via telephone or Skype and data
will be entered into REDCap™.
Data collection tools
The KTE Survey was developed through the Canadian
Partnership Against Cancer and is based on a tool devel-
oped by Skinner [30]. The survey includes items about
the participants’ demographics (e.g., role, designation,
organization type, province) and degree of agreement
with statements that the information was relevant and
useful, increased knowledge, and that stated learning
objectives were met. There are also items asking whether
the participant plans to discuss the information provided
at the session with colleagues or use the information to
make changes in practice.
The Education Roll-Out Report was developed by the
study team to collect the number of times each EPEC®-
Pediatrics module was offered along with the total number
of attendees at the session and whether the session was
held within the hospital or in the community. Regional
Teams will be asked to comment on any successes and
challenges in delivering the modules, indicate any ways
that the study team could provide additional supports to
assist in delivery of the modules and to describe plans for
delivery of sessions in the coming quarter.
Data analysis
Information obtained through the Education Roll-out
Report and the KTE Surveys will be summarized de-
scriptively. Our dissemination goal is to have a mini-
mum of 5 Master Facilitators, 45 Trainers, and 600 End-
Users from multiple professional groups across Canada
(see Fig. 1) take part in at least one EPEC®-Pediatrics
session. Our hypothesis is that the Trainers and End-
Users will indicate that the sessions were useful, im-
proved their knowledge related to the topic presented,
and had some impact on their practice. We will compare
the summarized responses to the Educational Report
and KTE Surveys with these goals and hypotheses to de-
termine if they have been achieved.
Stream 2 - Practice change outcomes
Data collection and analysis in Stream 2 will address the
impact of EPEC®-Pediatrics on practice change out-
comes; namely how many of the Regional Teams initiate
QI projects and achieve their practice change goals.
Procedure
Regional Teams at each of the 16 sites will be encour-
aged to complete and report on a QI project related to
the overall goals of the study to improve palliative care
for children with cancer. Teams may choose to use one
of the TIPS Kits that are available as part of the project,
or they may choose to do their own project. The EPEC®-
Pediatrics curriculum currently includes one TIPS Kit
on ‘symptom assessment’, with two additional kits under
development related to ‘identifying goals of care’ and ‘be-
reavement support’. Data will be collected about the QI
projects on a quarterly basis through a QI Progress Re-
port. The report will be completed verbally on a quar-
terly basis with the Project Manager/PIs via telephone or
Skype and data will be entered into REDCap™.
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Data collection tool
The QI Progress Report was developed by the study
team to collect information about progress made on the
QI projects. Information will be collected about the
practice improvement goals, strategies to achieve these
goals, a summary of audit and feedback results, plans for
the next quarter, as well as successes, challenges and
areas for further support.
Data analysis
QI Progress Report Data will be summarized descrip-
tively. Our goal is to have at least 10 of the 16 Regional
Teams successfully attain the practice improvement
goals set in their chosen QI project.
Stream 3 - Quality of care
Data collection and analysis in Stream 3 will address the
impact of EPEC®-Pediatrics on the quality of palliative
care provided to children with cancer and their families.
Quality of palliative care will be assessed using data from
three sources: A) surveys about symptoms, quality of
life, and care quality completed by children receiving ac-
tive treatment and their parents; B) review of health re-
cords of deceased patients; and C) surveys with bereaved
parents about the quality of their children’s end-of-life
care. Baseline data will be collected through each of the
16 pediatric oncology programs from January to April
2015, to provide a cross-sectional view of the quality of
palliative care prior to the EPEC®-Pediatrics roll-out.
The same data will be collected again from September
to November 2016 to determine the impact of the roll-
out on care quality.
Sample and procedure: A) Surveys during active treatment
Parents of children with a cancer diagnosis who are re-
ceiving treatment through one of the 16 pediatric oncol-
ogy programs in Canada will be invited, along with their
child, to complete a survey about symptoms, quality of
life, and care quality. Parents will be eligible to take part if
the child is less than 19 years of age, has a cancer diagno-
sis, and they are able to understand and read English or
French. Parents will be excluded if the child is disease-free
and has not received cancer-directed therapy in the last
3 months or if the health professional involved in their
care feels the family should not be approached for re-
search participation at this time (e.g., a recent relapse, dif-
ficulty coping with child’s illness, etc.). Children aged
seven years or older who meet the same criteria as the
parents will be invited to complete their own survey about
symptoms and quality of life.
The Parent Survey has been adapted from ‘The Sur-
vey About Caring for Children With Cancer’ (SCCC)
[9, 31, 32] and the ‘Quality of Children’s End-of-Life
Care Instrument’ (QCECI) [33]. The SCCC, developed by
one of our co-investigators (JW), is a widely used compre-
hensive, self-administered survey that evaluates parents’
perceptions of the child’s illness and care quality. It was ori-
ginally developed from a literature review and focus groups
with parents and health professionals to identify key do-
mains, and underwent pretesting to assess content, word-
ing, response burden, and cognitive validity [9, 31, 32]. The
QCECI was developed in a similar manner as the SCCC
and tested for reliability and validity by one of the co-PIs
(KW), with bereaved mothers [33]. It has also been adapted
and used with parents prior to the child’s death to assess
care quality. The Parent Survey will take approximately
15-30 min to complete.
The Child Survey consists of the ‘Memorial Symptom
Assessment Scale’ [25, 26] and the ‘Pediatric Quality of
Life Inventory’ (PedsQL™) 4.0 generic module [34] to as-
sess symptoms and quality of life as well as questions
asking how often they are asked about symptoms and
quality of life by health professionals. The Child Survey





3-5 health professionals at each of the 16 
pediatric oncology programs who will form a 
Regional Team
(48 to 80 Trainers in total)
END-USERS
40+ health professionals who provide care within the region associated with 
each of the 16 pediatric oncology programs
(numbers will vary by region but we expect a minimum of 600 End-Users to 
receive some portion of the EPEC-Pediatrics curriculum across Canada)
Fig. 1 Dissemination Goals
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Eligible children and parents will be approached dur-
ing an inpatient stay or regular clinic visit by their pri-
mary nurse or other health professional actively involved
in their care to see if they are interested in learning
more about our study. If so, the Research Assistant (RA)
will meet with the parent and child to provide further
information about the study. Assent/consent will be ob-
tained from eligible children and parents. If both parents
are present, they will be asked to choose one parent to
complete the survey. If the child is less than seven years
old or if the child does not wish to complete a survey,
the parent will still be asked to participate in the study.
The RA will have hard copies of all assent/consent forms
available, but the assent/consent forms will also appear
in REDCap™ prior to any questions being asked. Submis-
sion of the survey signifies assent/consent. Children and
parents who agree to take part will be given the option
of completing the survey with the RA (i.e., the RA would
access REDCap™, read the questions to the participant,
and enter the responses), providing an email address
where a link to the survey on REDCap™ can be sent, or
taking a business card that has the survey link written
on it so the participant can complete the survey on their
own. Children/adolescents will be offered a certificate of
completion for taking part in the study. Eligible chil-
dren/parents will be approached only once during each
data collection period to take part in the study; however,
a child/parent who was approached during the pre-test
period (Winter 2015) may be approached again during
the post-test period (Fall 2016) if they still meet the eligi-
bility criteria. Families who take part in both the pre-
and post-testing period will not have their responses
linked, as we are interested in cross-sectional data rather
than longitudinal.
Sample and procedure: B) Health record reviews
Health record reviews will be conducted for all chil-
dren with a cancer diagnosis who received treatment
at one of the 16 pediatric oncology programs and
died in the 12 months prior to the pre-test data col-
lection (January 2014 to January 2015) and in the
6 months prior to the post-test data collection (June
to November 2016).
Eligible deceased children will be identified through
the Health Records Department. An on-site RA will
review the health record and enter data directly into
REDCap™. Data collection forms were developed based
on previous health record reviews for children with can-
cer [9, 31, 32] and include information on diagnosis, age,
location of death, involvement of a palliative care team,
time spent in hospital during the last month of life, use
of cancer directed treatments, and documentation of
discussion of goals of care.
Sample and procedure: C) Bereaved parent surveys
During the pre and post-test period, bereaved parents
will be invited to complete a survey about the quality of
their children’s end-of-life care. Potential participants
will be identified according to the following inclusion
criteria: 1) Child died following a cancer diagnosis; 2)
Child aged 19 years or younger; 3) Parents are able to
read English or French. Parents will be excluded if: they
requested to have no further contact from the hospital
such as for bereavement follow-up support. Bereaved par-
ents will not be approached about the study until at least
6 months have passed since the time of the child’s death.
Therefore, in order to achieve the required sample size we
will invite parents whose child died during a 2 year win-
dow that ends 6 months prior to the end of the pre-test
data collection period (e.g. Invitation letters would be sent
in January 2015 to bereaved parents whose child died be-
tween July 2012 and July 2014) and in an 8 month window
that ends 6 months prior to the end of the post-test data
collection period (e.g. Invitation letters would be sent in
January 2017 to bereaved parents whose child died be-
tween December 2015 and July 2016).
The Bereaved Parent Survey was adapted from the
SCCC [9, 31, 32] and QCECI [33] to mirror the survey
used during active treatment, with additional items spe-
cific to the quality of end-of-life and bereavement care.
Contact information (name and mailing address) of eli-
gible parents will be obtained through Health Records. A
letter about the study will be sent to eligible parents from
someone who provided care to the family prior to the
child’s death or who is providing bereavement follow-up.
The letter will include a description of the study with in-
structions to access the survey online for submission via
REDCap™. The letter will also provide contact information
for a RA at the central study site if the parent wishes to
complete the survey with the RA by telephone or to re-
quest a hard copy to complete and return by mail. When
the parent accesses the survey online, the consent form
will appear prior to commencing the survey questions
along with a list of sources of support and information.
Submission of the survey will signify consent. The invita-
tion letter will also include a self-addressed stamped enve-
lope to be returned to the originating site if the parent
does not wish to have any further contact about the study
(opt-out). If an opt-out letter has not been received, a
thank you/reminder letter will be sent to all eligible par-
ents 3-4 weeks after the initial contact.
Sample size
The majority of quality indicators are categorical in nature
(i.e., proportion of children who die in preferred location,
proportion of children/parent who report symptoms in
the severe range); therefore, sample size for this compo-
nent of the project was calculated based on categorical
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analytic techniques. Specifically, sample size for standard
Chi-square analysis was conducted and increased by a fac-
tor equivalent to the assumed design effect due to the
clustering within regions. Given the timeline for the pro-
ject and the number of children that die from cancer
across Canada in a given year (~200), we will only be able
to collect data on 100 deceased children in the 6 months
following project implementation. However, retrospective
health record reviews and surveys can be completed for a
larger number of children at baseline. A prior study exam-
ining the effect of unit level interventions across 16
pediatric units across Canada, demonstrated moderate
intra-class correlations (ICCs) for knowledge outcomes,
but negligible ICCs for process and clinical outcomes [35];
therefore, a small ICC of 0.01 was used to adjust the sam-
ple size estimate to account for clustering within sites. We
will complete a minimum of 200 health record reviews/
surveys at baseline and 100 in the post-implementation
period across all 16 sites to detect a 15 % difference in out-
comes with 80 % power.
Data analysis
Categorical data (e.g., location of care/death) and continu-
ous data (e.g., parent reports of care quality scores) and will
be summarized and descriptively reported using frequen-
cies and proportions or means and standard deviations, re-
spectively. To identify differences in the quality indicators
between baseline and following implementation, marginal
regression models (i.e. Generalized Estimating Equation
models) will be used to model the outcome on time point
(i.e. pre- versus post-test) and account for clustering of out-
comes and practices of care within regions. All analyses
will be conducted using SAS v9.3. A p-value of 0.05 or less
will be used to indicate statistical significance.
Discussion
Though the original EPEC™ has been available since
1999, evaluation has thus far focused on dissemination
outcomes [20]; there has not been an attempt to meas-
ure the impact of EPEC™ on quality of care. However, as
with most education programs for health professionals,
the ultimate goal is that education will result in practice
changes and better care for patients. Our study will be a
significant step forward in evaluation of the impact of
EPEC®-Pediatrics both on dissemination outcomes and
on care quality at a national level.
Our study design and timelines will allow us to ad-
equately measure the impact of the EPEC®-Pediatrics
curriculum roll-out on self-assessed knowledge improve-
ments of health professionals; knowledge transfer and
dissemination outcomes; and practice change outcomes,
as has been done in the past [20]. However, our study
will be the first to examine the impact on a national
level. We have chosen a pre- post-test design to evaluate
our intervention in terms of its impact on quality of
care. A recent systematic review indicated that a train-
the-trainer model is effective in improving patient out-
comes; however, the length of the intervention and tim-
ing of data collection varied widely across studies [22].
Therefore, there is little evidence available to determine
an optimal length of the intervention or timing for out-
come assessment that could be used to guide a stronger
design, such as a cluster randomized controlled trial. It
is possible that a longer intervention period and a longer
follow-up period for post-test data collection may show
greater improvements in patient outcomes. Additionally,
though one of the strengths of EPEC®-Pediatrics is the
breadth of knowledge covered in the curriculum and the
flexibility that Trainers have in choosing which aspects
of the curriculum to present to End-Users, this flexibility
means that the roll-out may look very different across
the participating sites. To address some of the limita-
tions we will explore differences in how the curriculum
has been rolled out in each site (e.g., number and type of
education sessions, number of End-Users, type and suc-
cess of QI projects) and whether these differences are
associated with any differences in quality of palliative
care across sites. This exploration may help to identify
some core components of the curriculum that must be
included as part of the intervention and may advance
the science such that a stronger design could be used in
future research to roll-out the curriculum to health pro-
fessionals who care for children with life-threatening
illnesses other than cancer.
Our study is powered to detect changes in care quality.
However, even if no changes are seen in the course of
our study, measurement of the quality of palliative care
for children with cancer on a national level is an import-
ant aspect of our study and will be a significant contri-
bution to the field of pediatric oncology and palliative
care. This wealth of data can be used as the basis for fu-
ture research and targeted interventions to address spe-
cific issues nationally or locally. Ultimately our goal is to
enhance the care of all children who live with life-
threatening illnesses; we believe this study will be a sig-
nificant step forward in achieving that goal.
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